LMDX News and Press, LumiraDx Limited From 05/09/23

LONDON, May 09, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited  (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, announced it will release its first quarter financial results on Tuesday, May 16 t h , 2023. On the day of the release, LumiraDx will host a...

LONDON, April 24, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX)(the “Company”) today announced that it has received notification (the “Notification”) from The Nasdaq Stock Market LLC that it is not in compliance with the minimum bid price requirement in Nasd...

2023-04-11 08:00:38 ET President Joe Biden has signed legislation to end the U.S. national emergency to respond to the COVID-19 pandemic after bipartisan congressional support, weeks ahead of its expiry alongside a separate public health emergency. The move comes after the Senate cleare...

2023-04-06 09:34:36 ET Diagnostics testing solutions company LumiraDx ( NASDAQ: LMDX ) said on Thursday that it is set to reduce its headcount by ~40%. The move is a part of its strategic refocus and cost restructuring program, which aims to streamline strategic focus and oper...

LONDON, April 06, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a leading global provider of point-of-care diagnostics testing solutions, today announced its Strategic Refocus and Cost Restructuring Program aimed at reducing its scale and operations to pre-pandemic levels and to furth...

2023-04-05 07:07:35 ET A group of Democratic senators is requesting the Biden Administration to allow Medicare recipients to receive free-at-home COVID-19 tests even after the end of the public health emergency (PHE) next month. The group led by Sen. Bob Casey (D-PA) and Sen. Ron Wyden ...

2023-03-21 11:49:03 ET LumiraDx Limited (LMDX) Q4 2022 Earnings Conference Call March 21, 2023 08:30 AM ET Company Participants Melissa Garcia - Vice President Corporate Counsel Ron Zwanziger - Chairman and CEO Dorian LeBlanc - Chief Financial Officer Veroniq...

2023-03-21 08:16:19 ET The following slide deck was published by LumiraDx Limited in conjunction with their 2022 Q4 earnings call. For further details see: LumiraDx Limited 2022 Q4 - Results - Earnings Call Presentation

2023-03-21 07:30:08 ET LumiraDx press release ( NASDAQ: LMDX ): Q4 GAAP EPS of -$0.32 misses by $0.12 . Revenue of $41.12M (-65.2% Y/Y) misses by $2.34M . For further details see: LumiraDx GAAP EPS of -$0.32 misses by $0.12, revenue of $41.12M misses by $...

LONDON, March 21, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (NASDAQ: LMDX), a next-generation point of care (POC) diagnostics company, today announced financial results for its fourth quarter and full year ended December 31, 2022. Full year 2022 revenues of $254.5 million. Q4 2022 reven...